| 1. |
International Diabetes Federation. IDF diabetes atlas[M]. 7th ed. Brussels: International Diabetes Federation, 2015.
|
| 2. |
中華醫學會內分泌學分會. 中國成人2型糖尿病預防的專家共識[J]. 中華內分泌代謝雜志, 2014, 30(4): 277-283. DOI: 10.3760/cma.j.issn.1000-6699.2014.04.001.Chinese Society of Endocrnology. Expert consensus on prevention of type 2 diabetes mellitus in Chinese adult[J]. Chin J Endocrinol Metab, 2014, 30(4): 277-283. DOI: 10.3760/cma.j.issn.1000-6699.2014.04.001.
|
| 3. |
中華醫學會糖尿病學分會視網膜病變學組. 糖尿病視網膜病變防治專家共識[J]. 中華糖尿病雜志, 2018, 10(4): 241-247. DOI: 10.3760/cma.j.issn.1674-5809.2018.04.001.Chinese Diabetes Society Retinopathy Study Group of Chinese Medical Association. Expert consensus on prevention and treatment of diabetic retinopathy[J]. Chin J Diabetes Mellit, 2018, 10(4): 241-247. DOI: 10.3760/cma.j.issn.1674-5809.2018.04.001.
|
| 4. |
Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy[J]. Prog Retin Eye Res, 2016, 51: 156-186. DOI: 10.1016/j.preteyeres.2015.08.001.
|
| 5. |
劉曉欣, 劉心怡, 劉堃. 多不飽和脂肪酸在糖尿病視網膜病變炎癥中的作用機制研究進展[J]. 中華眼底病雜志, 2025, 41(4): 317-323. DOI: 10.3760/cma.j.cn511434-20240730-00290.Liu XX, Liu XY, Liu K. Research progress on the mechanisms of polyunsaturated fatty acids in inflammation of diabetic retinopathy[J]. Chin J Ocul Fundus Dis, 2025, 41(4): 317-323. DOI: 10.3760/cma.j.cn511434-20240730-00290.
|
| 6. |
許迅, 劉堃. 統一機制學說和慢性炎癥學說: 糖尿病視網膜病變基礎研究的新方向[J]. 中華眼底病雜志, 2008, 24(4): 237-239.Xu X, Liu K. Unifying mechanism theory and choronic inflammation theory: the trend of basic researches related to diabetic retinopathy[J]. Chin J Ocul Fundus Dis, 2008, 24(4): 237-239.
|
| 7. |
Guo H, Wu W, Huang Y, et al. Correlation between systemic inflammation and morphological changes of retinal neurovascular unit in patients with early signs of diabetic retinopathy: an OCT and OCT-angiography study[J]. Ophthalmic Res, 2025, 68(1): 263-274. DOI: 10.1159/000545097.
|
| 8. |
Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23): 6212-6222. DOI: 10.1158/1078-0432.Ccr-14-0442.
|
| 9. |
Li J, Wang X, Jia W, et al. Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications[J/OL]. Front Endocrinol (Lausanne), 2024, 15: 1367376[2024-04-10]. https://pubmed.ncbi.nlm.nih.gov/38660516/. DOI: 10.3389/fendo.2024.1367376.
|
| 10. |
Wang S, Pan X, Jia B, et al. Exploring the correlation between the systemic immune inflammation index (SII), systemic inflammatory response index (SIRI), and type 2 diabetic retinopathy[J]. Diabetes Metab Syndr Obes, 2023, 16: 3827-3836. DOI: 10.2147/dmso.S437580.
|
| 11. |
Gao Y, Lu RX, Tang Y, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in patients with type 2 diabetes at different stages of diabetic retinopathy[J]. Int J Ophthalmol, 2024, 17(5): 877-882. DOI: 10.18240/ijo.2024.05.12.
|
| 12. |
Elbeyli A, Kurtul BE, Ozcan SC, et al. The diagnostic value of systemic immune-inflammation index in diabetic macular oedema[J]. Clin Exp Optom, 2022, 105(8): 831-835. DOI: 10.1080/08164622.2021.1994337.
|
| 13. |
Gong Y, Wang L, Li Q, et al. Evaluating neutrophil-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index for diagnosing and predicting progression in diabetic retinopathy: a cross-sectional and longitudinal study[J/OL]. BMC Ophthalmol, 2025, 25(1): 398[2025-07-08]. https://pubmed.ncbi.nlm.nih.gov/40629269/. DOI: 10.1186/s12886-025-04222-5.
|
| 14. |
Hartwell ML, Khojasteh J, Wetherill MS, et al. Using structural equation modeling to examine the influence of social, behavioral, and nutritional variables on health outcomes based on NHANES data: addressing complex design, nonnormally distributed variables, and missing information[J/OL]. Curr Dev Nutr, 2019, 3(5): nzz010[2019-02-04]. https://pubmed.ncbi.nlm.nih.gov/31008441/. DOI: 10.1093/cdn/nzz010.
|
| 15. |
Wei ZM, Zhao Y, Ding RR, et al. Combination of red blood cell distribution width and platelet-to-lymphocyte ratio for predicting severity of diabetic retinopathy[J]. Int J Ophthalmol, 2025, 18(8): 1506-1514. DOI: 10.18240/ijo.2025.08.12.
|
| 16. |
Xu L, Lin X, Li T, et al. Association between prognostic nutritional index and diabetic retinopathy among U. S. diabetic adults in NHANES[J/OL]. Sci Rep, 2025, 15(1): 12986[2025-04-15]. https://pubmed.ncbi.nlm.nih.gov/40234618/. DOI: 10.1038/s41598-025-96582-7.
|
| 17. |
Dai H, Liu L, Xu W. Association of albumin-to-creatinine ratio with diabetic retinopathy among US adults (NHANES 2009-2016)[J/OL]. Endocrinol Diabetes Metab, 2025, 8(1): e70029[2025-01-01]. https://pubmed.ncbi.nlm.nih.gov/39826101/. DOI: 10.1002/edm2.70029.
|
| 18. |
Chen X, Sun M, Gu Z, et al. Association of serum selenium levels with diabetic retinopathy: NHANES 2011-2016[J/OL]. Front Med (Lausanne), 2025, 12: 1546214[2025-04-04]. https://pubmed.ncbi.nlm.nih.gov/40255593/. DOI: 10.3389/fmed.2025.1546214.
|
| 19. |
Eshaq RS, Harris NR. The role of tumor necrosis factor-α and interferon-γ in the hyperglycemia-induced ubiquitination and loss of platelet endothelial cell adhesion molecule-1 in rat retinal endothelial cells[J/OL]. Microcirculation, 2021, 28(7): e12717[2021-05-29]. https://pubmed.ncbi.nlm.nih.gov/34008903/. DOI: 10.1111/micc.12717.
|
| 20. |
Tian BW, Yang YF, Yang CC, et al. Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis[J]. Immunotherapy, 2022, 14(18): 1481-1496. DOI: 10.2217/imt-2022-0133.
|
| 21. |
He L, Xie X, Xue J, et al. Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease[J/OL]. Front Cardiovasc Med, 2022, 9: 952953[2022-09-12]. https://pubmed.ncbi.nlm.nih.gov/36172591/. DOI: 10.3389/fcvm.2022.952953.
|
| 22. |
Li H, Wu X, Bai Y, et al. Physical activity attenuates the associations of systemic immune-inflammation index with total and cause-specific mortality among middle-aged and older populations[J/OL]. Sci Rep, 2021, 11(1): 12532[2021-06-15]. https://pubmed.ncbi.nlm.nih.gov/34131164/. DOI: 10.1038/s41598-021-91324-x.
|
| 23. |
Xie R, Xiao M, Li L, et al. Association between SII and hepatic steatosis and liver fibrosis: a population-based study[J/OL]. Front Immunol, 2022, 13: 925690[2022-09-15]. https://pubmed.ncbi.nlm.nih.gov/36189280/. DOI: 10.3389/fimmu.2022.925690.
|
| 24. |
Mahemuti N, Jing X, Zhang N, et al. Association between systemic immunity-inflammation index and hyperlipidemia: a population-based study from the NHANES (2015-2020)[J/OL]. Nutrients, 2023, 15(5): 1177[2023-02-26]. https://pubmed.ncbi.nlm.nih.gov/36904176/. DOI: 10.3390/nu15051177.
|
| 25. |
Liu B, Wang J, Li YY, et al. The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999-2018[J/OL]. Arthritis Res Ther, 2023, 25(1): 34[2023-03-04]. https://pubmed.ncbi.nlm.nih.gov/36871051/. DOI: 10.1186/s13075-023-03018-6.
|
| 26. |
Kelesoglu Dincer AB, Sezer S. Systemic immune inflammation index as a reliable disease activity marker in psoriatic arthritis[J]. J Coll Physicians Surg Pak, 2022, 32(6): 773-778. DOI: 10.29271/jcpsp.2022.06.773.
|
| 27. |
Yorulmaz A, Hayran Y, Akpinar U, et al. Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis[J]. Curr Health Sci J, 2020, 46(4): 352-357. DOI: 10.12865/chsj.46.04.05.
|
| 28. |
Dascalu AM, Serban D, Tanasescu D, et al. The value of white cell inflammatory biomarkers as potential predictors for diabetic retinopathy in type 2 diabetes mellitus (T2DM)[J/OL]. Biomedicines, 2023, 11(8): 2106[2023-07-26]. https://pubmed.ncbi.nlm.nih.gov/37626602/. DOI: 10.3390/biomedicines11082106.
|
| 29. |
Liu J, Liu X, Li Y, et al. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis[J/OL]. Biosci Rep, 2018, 38(3): BSR20180172[2018-06-27]. https://pubmed.ncbi.nlm.nih.gov/29581246/. DOI: 10.1042/bsr20180172.
|
| 30. |
Dascalu AM, Georgescu A, Costea AC, et al. Association between neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with diabetic retinopathy in type 2 diabetic patients[J/OL]. Cureus, 2023, 15(11): e48581[2023-11-09]. https://pubmed.ncbi.nlm.nih.gov/38090430/. DOI: 10.7759/cureus.48581.
|
| 31. |
Ji S, Ning X, Zhang B, et al. Platelet distribution width, platelet count, and plateletcrit in diabetic retinopathy: a systematic review and meta-analysis of PRISMA guidelines[J/OL]. Medicine (Baltimore), 2019, 98(29): e16510[2019-07-01]. https://pubmed.ncbi.nlm.nih.gov/31335726/. DOI: 10.1097/md.0000000000016510.
|
| 32. |
Wang X, Jiang H, Zhang C. Association of systemic inflammatory biomarkers with ocular disease: a large population-based cross-sectional study[J/OL]. Eur J Med Res, 2025, 30(1): 206[2025-03-26]. https://pubmed.ncbi.nlm.nih.gov/40140856/. DOI: 10.1186/s40001-025-02473-y.
|
| 33. |
Guo S, Pang Y, Bao T, et al. Evaluating systemic immune-inflammation index and mortality in diabetic retinopathy: a NHANES 2005-2018 cohort study[J]. Ophthalmol Ther, 2026, 15(2): 843-854. DOI: 10.1007/s40123-026-01314-3.
|
| 34. |
Deng R, Zhu S, Fan B, et al. Exploring the correlations between six serological inflammatory markers and different stages of type 2 diabetic retinopathy[J/OL]. Sci Rep, 2025, 15(1): 1567[2028-01-10]. https://pubmed.ncbi.nlm.nih.gov/39794420/. DOI: 10.1038/s41598-025-85164-2.
|
| 35. |
昌路艷, 杜瑞琴. 全身免疫-炎癥指數與糖尿病視網膜病變相關性分析[J]. 聯勤軍事醫學, 2023, 37(7): 581-584. DOI: 10.13730/j.issn.2097-2148.2023.07.008.Chang LY, Du RQ. Correlation analysis between systemic immune-inflammation index and diabetic retinopathy[J]. J Log Mil Med, 2023, 37(7): 581-584. DOI: 10.13730/j.issn.2097-2148.2023.07.008.
|
| 36. |
Guo W, Song Y, Sun Y, et al. Systemic immune-inflammation index is associated with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from NHANES 2011-2018[J/OL]. Front Endocrinol (Lausanne), 2022, 13: 1071465[2022-12-06]. https://pubmed.ncbi.nlm.nih.gov/36561561/. DOI: 10.3389/fendo.2022.1071465.
|
| 37. |
徐文彥, 張淼. 系統免疫炎癥指數與成人糖尿病患者全因及心血管疾病死亡率的相關性研究[J]. 中華糖尿病雜志, 2024, 16(9): 996-1005. DOI: 10.3760/cma.j.cn115791-20240319-00121.Xu WY, Zhang M. Association between systemic immune-inflammation index and all-cause and cardiovascular disease mortality in adult patients with diabetes[J]. Chin J Diabetes Mellit, 2024, 16(9): 996-1005. DOI: 10.3760/cma.j.cn115791-20240319-00121.
|
| 38. |
Wang X, Wang L, Li X, et al. Characteristics of hematologic parameters in young patients with retinal vein occlusion[J]. Ophthalmic Res, 2023, 66(1): 1096-1103. DOI: 10.1159/000531824.
|
| 39. |
Patro S, Sharma V, Choudhary A, et al. Systemic immune-inflammation index (SII) of patients with and without diabetic neuropathy: a cross-sectional study[J/OL]. Cureus, 2025, 17(7): e87759[2025-07-12]. https://pubmed.ncbi.nlm.nih.gov/40792338/. DOI: 10.7759/cureus.87759.
|